A heterologous vaccine (also known as a "Jennerian" vaccine) is a type of live vaccine where one pathogen is introduced in order to provide protection against a different one. The vaccines are pathogens of other animals that either do not cause disease or cause mild disease in the organism being treated.
- historically, Jenner's administration of cowpox (vaccinia) to protect against smallpox (variola);
- the administration of BCG vaccine made from Mycobacterium bovis to protect against human tuberculosis.
Like all live vaccines, it has the advantage that it replicates in the body, and therefore reduces the need for booster shots. It has the disadvantage that a potential pathogen is introduced into the body.
- Scott (April 2004). "Classifying Vaccines" (PDF). BioProcesses International: 14–23. Retrieved 2014-01-09.
- Ho SY, Chua SQ, Foo DG, et al. (January 2008). "Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates". Infect. Immun. 76 (1): 111–9. PMC . PMID 17954727. doi:10.1128/IAI.00795-07.
|This vaccine article is a stub. You can help Wikipedia by expanding it.|